It’s certainly billions (just for a positive OSA outcome) yet the rank and file are folding like a cheap lawn chair because they have not or are incapable of determining the value of the clinical programs. But they will here in the US and compared to the peers on NASDAQ this company will be received extremely well IMO.
IHL Price at posting:
7.4¢ Sentiment: Buy Disclosure: Held